Evidence map›Paper›PMID 26613957›Full record

ArticleEuropean journal of immunology2016

IRF5 and IRF8 modulate the CAL-1 human plasmacytoid dendritic cell line response following TLR9 ligation.

Folkert Steinhagen, Luis G Rodriguez, Debra Tross, Poonam Tewary, Christian Bode, Dennis M Klinman

Open access · hybridAbstract read
In one paragraph

Article in European journal of immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Type I Interferon Production of Plasmacytoid Dendritic Cells under Control.International journal of molecular sciences · 2021
    Review
  7. Review
  8. Review
  9. Regulatory role of SphK1 in TLR7/9-dependent type I interferon response and autoimmunity.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Folkert SteinhagenCancer and Inflammation Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Luis G RodriguezCancer and Inflammation Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Debra TrossCancer and Inflammation Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Poonam TewaryCancer and Inflammation Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Christian BodeCancer and Inflammation Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Dennis M KlinmanCancer and Inflammation Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Frederick National Laboratory for Cancer Research · USUniversity Hospital Bonn · DE

Funding

Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotidesZIABC010852 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KLINMAN, DENNIS · 2009 to 2019
$11.3M
Mechanism of action and therapeutic utility of immunostimulatory CpG oligonucleoZ01BC010852 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KLINMAN, DENNIS · 2007 to 2008
$1.9M
Intramural NIH HHS Z01 BC010852
6 · The paper itself

Abstract

Synthetic oligonucleotides (ODNs) containing CpG motifs stimulate human plasmacytoid dendritic cells (pDCs) to produce type-1 interferons (IFNs) and proinflammatory cytokines. Previous studies demonstrated that interferon regulatory factors (IRFs) play a central role in mediating CpG-induced pDC activation. This work explores the inverse effects of IRF5 and IRF8 (also known as IFN consensus sequence-binding protein) on CpG-dependent gene expression in the human CAL-1 pDC cell line. This cell line shares many of the phenotypic and functional properties of freshly isolated human pDCs. Results from RNA interference and microarray studies indicate that IRF5 upregulates TLR9-driven gene expression whereas IRF8 downregulates the same genes. Several findings support the conclusion that IRF8 inhibits TLR9-dependent gene expression by directly blocking the activity of IRF5. First, the inhibitory activity of IRF8 is only observed when IRF5 is present. Second, proximity ligation analysis shows that IRF8 and IRF5 colocalize within the cytoplasm of resting human pDCs and cotranslocate to the nucleus after CpG stimulation. Taken together, these findings suggest that IRF5 and IRF8, two transcription factors with opposing functions, control TLR9 signaling in human pDCs.

Indexed as

Cell LineCytokinesDendritic CellsDown-RegulationGene Expression RegulationHumansInterferon Regulatory Factor-8Interferon Regulatory FactorsMicroarray AnalysisOligodeoxyribonucleotidesRNA InterferenceSignal TransductionToll-Like Receptor 9CPG-oligonucleotideCytokinesInterferon Regulatory Factor-8Interferon Regulatory FactorsIRF5 protein, humanOligodeoxyribonucleotidesToll-Like Receptor 9CpG oligonucleotideDendritic cellIRF8, IRF5TLR9

Identifiers

PMID26613957
PMCPMC6385590
OpenAlexW2173725402

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.